Rock Springs Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5M | Buy |
|
|||||
|
2025
Q1 | $33.7M | Sell |
|
|||||
|
2024
Q4 | $42M | Sell |
|
|||||
|
2024
Q3 | $48.5M | Buy |
|
|||||
|
2024
Q2 | $39.6M | Hold |
|
|||||
|
2024
Q1 | $43.8M | Hold |
|
|||||
|
2023
Q4 | $36.5M | Sell |
|
|||||
|
2023
Q3 | $39.8M | Hold |
|
|||||
|
2023
Q2 | $38M | Hold |
|
|||||
|
2023
Q1 | $45.6M | Hold |
|
|||||
|
2022
Q4 | $52M | Hold |
|
|||||
|
2022
Q3 | $43.9M | Hold |
|
|||||
|
2022
Q2 | $39.6M | Buy |
|
|||||
|
2022
Q1 | $49M | Buy |
|
|||||
|
2021
Q4 | $53.8M | Hold |
|
|||||
|
2021
Q3 | $63.8M | Buy |
|
|||||
|
2021
Q2 | $30.7M | Hold |
|
|||||
|
2021
Q1 | $30.1M | Hold |
|
|||||
|
2020
Q4 | $38.9M | Hold |
|
|||||
|
2020
Q3 | $36M | Buy |
|
|||||
|
2020
Q2 | $31.6M | Hold |
|
|||||
|
2020
Q1 | $24M | Hold |
|
|||||
|
2019
Q4 | $29.7M | Hold |
|
|||||
|
2019
Q3 | $20.6M | Hold |
|
|||||
|
2019
Q2 | $24.6M | Hold |
|
|||||
|
2019
Q1 | $25.1M | Sell |
|
|||||
|
2018
Q4 | $15.3M | Hold |
|
|||||
|
2018
Q3 | $17.3M | Hold |
|
|||||
|
2018
Q2 | $16.2M | Sell |
|
|||||
|
2018
Q1 | $18.5M | Buy |
|
|||||
|
2017
Q4 | $11.2M | Hold |
|
|||||
|
2017
Q3 | $10.2M | Sell |
|
|||||
|
2017
Q2 | $9.02M | Hold |
|
|||||
|
2017
Q1 | $9.1M | Hold |
|
|||||
|
2016
Q4 | $6.58M | Buy |
|
|||||
|
2016
Q3 | $6.03M | Hold |
|
|||||
|
2016
Q2 | $3.98M | Buy |
|
|||||
|
2016
Q1 | $5.01M | Hold |
|
|||||
|
2015
Q4 | $4.95M | Hold |
|
|||||
|
2015
Q3 | $4.78M | Buy |
|
|||||
|
2015
Q2 | $4.24M | Buy |
|
|||||
|
2015
Q1 | $617K | Buy |
|